Results 131 to 140 of about 2,667,700 (378)
High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department [PDF]
, 2017 Evaluating patients with acute chest pain presenting to the emergency department remains an ongoing challenge. The spectrum of etiologies in acute chest pain ranges from minor disease entities to life-threatening diseases, such as pulmonary embolism ...
Bahrmann, Philipp +5 more
core
Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML
American Journal of Hematology, EarlyView.
Nia Choi +11 more
wiley +1 more source
A mouse model of lung ischemia–reperfusion injury with reversible left hilar entrapment
Animal Models and Experimental Medicine, EarlyView.A Novel Reversible Left Hilar Entrapment Model for Mouse Lung Ischemia‐Reperfusion Injury with Visual Tracheal Intubation and Live Knot Technique. Abstract Lung ischemia–reperfusion injury (LIRI), an acute lung injury syndrome triggered by lung transplantation or distal organ ischemia, has long been a difficult and hot issue in clinical research.
GuangDong Weng +4 more
wiley +1 more source
Hydatid cyst of lung: An uncommon cause of chest pain in young
Lung India, 2014 Echinococcosis can involve any organ. The liver is the most common organ involved, followed by the lungs. Depending on the location of involvement it can have varied presentation.
S R Kalpana +4 more
doaj +1 more source
Development of Chest Pain in Munchausen's Syndrome [PDF]
, 1960 Mohammad Peyman
openalex +1 more source
In-flight Medical Emergency: An experience with Singapore Airlines [PDF]
, 2009 In-flight medical emergencies are becoming a concern to airlines and their passengers in light of the increasing number of air passengers. The SQ flight was from Sydney, Australia to Singapore. The whole journey took about eight hours.
Wong, Kam Cheong
core
Annals of Neurology, EarlyView.Objective Elezanumab is a monoclonal antibody that binds repulsive guidance molecule a (RGMa), an inhibitor of central nervous system regeneration after inflammation or injury. The aim was to assess the safety and efficacy of elezanumab in relapsing and progressive forms of multiple sclerosis (MS).
Bruce A.C. Cree +6 more
wiley +1 more source
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
Annals of Neurology, EarlyView.Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam +29 more
wiley +1 more source